Literature DB >> 17434359

An 18-year review of open and laparoscopic splenectomy for idiopathic thrombocytopenic purpura.

Sharadh Sampath1, Adam T Meneghetti, John K MacFarlane, Nam H Nguyen, W Barrett Benny, Ormond N M Panton.   

Abstract

BACKGROUND: Laparoscopic splenectomy has become the preferred surgical procedure for the management of idiopathic thrombocytopenic purpura (ITP). However, there studies have directly compared the incidence of recurrent ITP secondary to missed accessory spleens in open versus laparoscopic splenectomy.
METHODS: Open and laparoscopic splenectomies performed for ITP at 4 sites over 18 years were analyzed. The incidence of recurrent disease secondary to missed accessory spleens was compared between the open and laparoscopic splenectomy groups.
RESULTS: A total of 105 splenectomies (54 open/51 laparoscopic) were performed. Accessory spleens were identified in 6 laparoscopic and 6 open cases (P = .57). Recurrent disease occurred in 27.6% of open and 14.6% of laparoscopic cases (P = .222). There were no cases of recurrent ITP secondary to a missed accessory spleen in either group.
CONCLUSIONS: The incidence of missed accessory spleens causing recurrent disease is similar when splenectomy is performed either open or laparoscopically.

Entities:  

Mesh:

Year:  2007        PMID: 17434359     DOI: 10.1016/j.amjsurg.2007.02.002

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  23 in total

Review 1.  Laparoscopic splenectomy: standardized approach.

Authors:  Liane S Feldman
Journal:  World J Surg       Date:  2011-07       Impact factor: 3.352

Review 2.  Evidence-based management of immune thrombocytopenia: ASH guideline update.

Authors:  Cindy E Neunert; Nichola Cooper
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

3.  Laparoscopic splenectomy: a personal series of 140 consecutive cases.

Authors:  Clare J Pattenden; Christopher D Mann; Matthew S Metcalfe; Martin Dyer; David M Lloyd
Journal:  Ann R Coll Surg Engl       Date:  2010-05-19       Impact factor: 1.891

4.  Laparoscopic splenectomy is a better surgical approach for spleen-relevant disorders: a comprehensive meta-analysis based on 15-year literatures.

Authors:  Ji Cheng; Kaixiong Tao; Peiwu Yu
Journal:  Surg Endosc       Date:  2016-02-19       Impact factor: 4.584

5.  Laparoscopic splenectomy for splenic hamartoma: Case management and clinical consequences.

Authors:  Tsutomu Namikawa; Hiroyuki Kitagawa; Jun Iwabu; Michiya Kobayashi; Manabu Matsumoto; Kazuhiro Hanazaki
Journal:  World J Gastrointest Surg       Date:  2010-04-27

6.  Long-term outcomes of laparoscopic versus open splenectomy for immune thrombocytopenia.

Authors:  Kazuhiro Tada; Masayuki Ohta; Kunihiro Saga; Hiroomi Takayama; Teijiro Hirashita; Yuichi Endo; Hiroki Uchida; Yukio Iwashita; Masafumi Inomata
Journal:  Surg Today       Date:  2017-07-19       Impact factor: 2.549

Review 7.  Laparoscopic splenectomy for primary immune thrombocytopenia: Current status and challenges.

Authors:  Dong Zheng; Chen-Song Huang; Shao-Bin Huang; Chao-Xu Zheng
Journal:  World J Gastrointest Endosc       Date:  2016-09-16

8.  Laparoscopic splenectomy: the clinical practice guidelines of the European Association for Endoscopic Surgery (EAES).

Authors:  B Habermalz; S Sauerland; G Decker; B Delaitre; J-F Gigot; E Leandros; K Lechner; M Rhodes; G Silecchia; A Szold; E Targarona; P Torelli; E Neugebauer
Journal:  Surg Endosc       Date:  2008-02-22       Impact factor: 4.584

9.  Should we routinely transfuse platelet for immune thrombocytopenia patients with platelet count less than 10 × 10⁹/L who underwent laparoscopic splenectomy?

Authors:  Yunqiang Cai; Xubao Liu; Bing Peng
Journal:  World J Surg       Date:  2014-09       Impact factor: 3.352

10.  Clinical significance of single-port laparoscopic splenectomy: comparison of single-port and multiport laparoscopic procedure.

Authors:  Eui Soo Han; Young Kyoung You; Dong Goo Kim; Jun Suh Lee; Eun Young Kim; Soo Ho Lee; Tae Ho Hong; Gun Hyung Na
Journal:  Ann Surg Treat Res       Date:  2015-07-09       Impact factor: 1.859

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.